Improving HIV prevention and care for transgender women by addressing trauma

A trauma-informed approach to improve engagement in HIV prevention and HIV care among transgender women

['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10924921

This study is looking to improve how transgender women access HIV prevention and care by understanding how trauma affects their mental health and willingness to seek help, and it will also test a new program in clinics to see if it makes it easier for them to get the support they need.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded)
Locations1 site (SAN FRANCISCO, UNITED STATES)
Trial IDNIH-10924921 on ClinicalTrials.gov

What this research studies

This research focuses on enhancing engagement in HIV prevention and care among transgender women, who are significantly affected by HIV but often face barriers to accessing services. The study will explore the impact of trauma on mental health and HIV care engagement through interviews with transgender women and clinic stakeholders. It will also pilot a trauma screening and intervention program in community clinics to assess its effectiveness in improving care access. By addressing the psychosocial factors that hinder engagement, the research aims to create a supportive environment for transgender women seeking HIV services.

Who could benefit from this research

Good fit: Ideal candidates for participation are transgender women who are at risk for HIV and seeking care or prevention services.

Not a fit: Patients who do not identify as transgender or those who are not at risk for HIV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved HIV prevention and care engagement for transgender women, ultimately reducing HIV transmission rates in this vulnerable population.

How similar studies have performed: Previous research has shown that trauma-informed approaches can improve health outcomes in marginalized populations, suggesting potential success for this novel application.

Where this research is happening

SAN FRANCISCO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.